A multicenter, open-label phase II trial of secondline apatinib plus irinotecan in patients with advanced gastric cancer

被引：0
|
作者：
Peng, Jianjun
Li, Yong
Xiao, Jianjun
Liu, Huaqiang
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Tradit Chinese Med Hosp Guangdong Prov, Guangzhou, Peoples R China
[3] Zhongshan City Peoples Hosp, Zhongshan, Peoples R China
[4] Cent Hosp Guangdong Prov Agr Reclamat, Zhanjiang, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.287
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
287
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Pemetrexed plus oxaliplatin in the management of advanced gastric cancer:: A multicenter phase II trial
    Bajetta, Emilio
    Celio, Luigi
    Calabro, Fabio
    Mosconi, Stefania
    La Torre, Ignazia
    Barone, Carlo
    Berardi, Rossana
    Amoroso, Vito
    Pinotti, Graziella
    Di Costanzo, Francesco
    ANNALS OF ONCOLOGY, 2006, 17 : 313 - 313
  • [32] Efficacy and safety of sintilimab plus XELOX as neoadjuvant therapy in patients with locally advanced gastric cancer: A single-arm open-label phase II trial.
    Guo, Honghai
    Ding, Ping'an
    Yang, Peigang
    Tian, Yuan
    Liu, Yang
    Zhang, Ze
    Zheng, Tao
    Zhang, Zhidong
    Wang, Dong
    Tan, Bibo
    Zhao, Xuefeng
    Li, Yong
    Zhao, Qun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16091 - E16091
  • [33] Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: A single-arm, open-label, phase 2 trial
    Wei, Zhigong
    Zhu, Yuchun
    Cai, Lei
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial
    Kim, Seung Tae
    Oh, Sung Yong
    Lee, Jeeyun
    Kang, Jung Hun
    Lee, Hyun Woo
    Lee, Myung Ah
    Sohn, Byeong Seok
    Hong, Ji Hyong
    Park, Young Suk
    Park, Joon Oh
    Lim, Ho Yeong
    JOURNAL OF CANCER, 2019, 10 (25): : 6185 - 6190
  • [35] Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancer
    Rosati, G.
    Cordio, S.
    Caputo, G.
    Condorelli, S.
    Germano, D.
    Mattina, M.
    Amadio, P.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 189 - 189
  • [36] Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
    Simonelli, M.
    Garralda, E.
    Eskens, F.
    Gil-Martin, M.
    Yen, C-J
    Obermannova, R.
    Chao, Y.
    Lonardi, S.
    Melichar, B.
    Moreno, V
    Yu, M-L
    Bongiovanni, A.
    Calvo, E.
    Rottey, S.
    Machiels, J-P
    Gonzalez-Martin, A.
    Paz-Ares, L.
    Chang, C-L
    Mason, W.
    Lin, C-C
    Reardon, D. A.
    Vieito, M.
    Santoro, A.
    Meng, R.
    Abbadessa, G.
    Menas, F.
    Lee, H.
    Liu, Q.
    Combeau, C.
    Ternes, N.
    Ziti-Ljajic, S.
    Massard, C.
    ESMO OPEN, 2022, 7 (05)
  • [37] Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancer
    Rosati, G.
    Cordio, S.
    Caputo, G.
    Condorelli, S.
    Germano, D.
    Mattina, M.
    Amadio, P.
    Reggiardo, G.
    Manzione, L.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) : 570 - 576
  • [38] A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
    Hanibuchi, Masaki
    Kakiuchi, Soji
    Atagi, Shinji
    Ogushi, Fumitaka
    Shimizu, Eiji
    Haku, Takashi
    Toyoda, Yuko
    Azuma, Masahiko
    Kondo, Mayo
    Kawano, Hiroshi
    Otsuka, Kenji
    Sakaguchi, Satoshi
    Nokihara, Hiroshi
    Goto, Hisatsugu
    Nishioka, Yasuhiko
    LUNG CANCER, 2018, 125 : 93 - 99
  • [39] OPEN-LABEL PHASE II STUDY OF SORAFENIB plus DACARBAZINE IN PATIENTS WITH ADVANCED METASTATIC MELANOMA
    Gonzalez-Larriba, J. L.
    Guillem, V.
    Marmol, M.
    Valladares, M.
    Arrivi, A.
    Pastor, P.
    Garcia-Garcia, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 246 - 246
  • [40] A Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease
    Hanibuchi, M.
    Kakiuchi, S.
    Atagi, S.
    Ogushi, F.
    Shimizu, E.
    Haku, T.
    Toyoda, Y.
    Azuma, M.
    Kondo, M.
    Kawano, H.
    Otsuka, K.
    Sakaguchi, S.
    Nokihara, H.
    Goto, H.
    Nishioka, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S472 - S472
12345